Men can absolutely get breast or chest implants, and thousands do every year. The procedures fall into two broad categories that look quite different from each other: cisgender men who want a more muscular-looking chest through pectoral implants, and transgender women who seek breast augmentation as part of gender-affirming care. Both involve surgically placing implants in the chest, but the goals, implant types, placement techniques, and even the follow-up considerations diverge in ways worth understanding before making any decisions.
Pectoral Implants for a More Muscular Chest
Pectoral implants were originally developed for men with congenital conditions or injuries that left one or both sides of the chest underdeveloped. Over time, as cultural ideals around male physique shifted, the procedure expanded into the cosmetic realm. Today, more men request pectoral implants purely to add size and definition to a chest that has not responded to exercise the way they want.1PubMed Central. Male Pectoral Implants: Radiographic Appearance of Complications
The implants used for this purpose are solid silicone blocks, not the gel-filled or saline-filled shells used in traditional breast augmentation. A surgeon typically makes an incision in the armpit, creates a pocket beneath the pectoralis major muscle, and slides the implant into place. In one published case series of 21 patients, the procedure produced consistent chest contour enhancement with no major complications. Most of those patients were healthy men seeking a cosmetic boost, though a few had muscle atrophy or prior injuries.2PubMed. Male chest enhancement: pectoral implants
That said, pectoral implants are not risk-free. Documented complications include implant displacement, fluid buildup around the implant, and in rare cases near-extrusion, where the implant migrates close to pushing through tissue. One case report described a 44-year-old man whose left pectoral implant shifted significantly, leading to a soft-tissue mass and fluid collection that required imaging and further treatment.1PubMed Central. Male Pectoral Implants: Radiographic Appearance of Complications Because the procedure is relatively uncommon compared to standard breast augmentation, surgeons encounter fewer of these complications in daily practice, which can make recognizing and managing them slower when they do arise.
Breast Augmentation for Transgender Women
For transgender women, breast augmentation is frequently described as the most important, and sometimes the only, surgical procedure they pursue as part of their transition.3PubMed Central. Breast augmentation for transfeminine patients: methods, complications, and outcomes The surgery uses standard silicone gel or saline breast implants, the same devices used in augmentation for cisgender women. Placement is typically subpectoral (behind the chest muscle) or in a dual-plane position, depending on how much existing breast tissue and skin coverage is available.
The reason this procedure carries so much weight for many trans women is that hormone therapy, while it does promote breast growth, often does not produce enough volume to match the person’s goals. Research on trans women receiving feminizing hormones has found that the median breast volume achieved through hormones alone is around 115 mL, which corresponds to less than an A cup.4The Journal of Clinical Endocrinology & Metabolism. Variations in Volume: Breast Size in Trans Women in Relation to Timing of Testosterone Suppression For many, that result falls short of what feels right, making implants an important next step.
Why Anatomy Matters for Surgical Planning
A cisgender male chest and a cisgender female chest differ in ways that affect how breast augmentation is performed. Trans women who have been on estrogen develop breast tissue, but the underlying skeletal structure, skin envelope, and soft-tissue proportions often retain characteristics of the male chest. One study comparing preoperative measurements between cisgender women and trans women found significant differences in breast width and the distance from the sternal notch to the nipple, even though the nipple-to-fold distance was similar between groups. The ratio of breast width to nipple-to-fold distance was meaningfully different, which tells surgeons that simply using the same implant selection approach as for cisgender women can lead to suboptimal results.5PubMed Central. Differences in Chest Measurements between the Cis-female and Trans-female Chest Exposed to Estrogen and Its Implications for Breast Augmentation
In practical terms, trans women tend to have wider chests, less soft-tissue coverage, and a broader spacing between breasts. These differences mean the surgeon may need to choose wider, lower-profile implants to avoid an unnatural “stuck-on” look. It also means the skin and tissue may be thinner over the implant edges, which can make rippling or visible implant borders more likely if implant selection is not carefully tailored.
How Hormone Therapy Shapes the Starting Point
Many trans women wonder whether starting hormones earlier leads to meaningfully larger breasts. The data on this is less dramatic than you might expect. A study examining breast volume in trans women who began puberty suppression early versus those who started later, as well as those who began hormones in adulthood, found that the raw difference in breast volume between early and late suppression groups was about 47 mL. But once the researchers accounted for differences in body fat percentage, that gap shrank to just 4 mL. Breast volume in the adult-onset group was comparable to both of the other groups.4The Journal of Clinical Endocrinology & Metabolism. Variations in Volume: Breast Size in Trans Women in Relation to Timing of Testosterone Suppression
What this suggests is that overall body composition, particularly fat percentage, drives a lot of the variation in hormone-induced breast size. Starting hormones earlier does not guarantee noticeably larger breasts if the person is lean. This finding is reassuring for trans women who begin hormones later in life, but it also underscores why many pursue augmentation regardless of when they started hormones.
Complication Rates Compared
A natural question is whether breast augmentation carries different risks depending on whether you are a cisgender woman or a transgender woman. A large database study looking at procedures between 2007 and 2016 identified over 4,200 breast augmentations in cisgender women and 137 in transgender women. The transgender group had higher rates of certain pre-existing health conditions, including diabetes, smoking, and high blood pressure. Despite those differences, the actual surgical outcomes were comparable. Rates of surgical site infections, blood clots, bleeding, 30-day mortality, prolonged hospitalization, readmission, and reoperation showed no significant differences between the two groups.6PubMed Central. A comparison of perioperative safety for breast augmentation in cis- vs. trans patients
Looking at longer-term outcomes specifically in trans women, a systematic review and meta-analysis calculated pooled complication rates across multiple studies. Capsular contracture, where scar tissue tightens around the implant and makes the breast feel hard, occurred at a rate of about 3.6%. Hematoma or seroma (blood or fluid collection) appeared in about 0.6% of cases, and infection in less than 0.1%. Implant asymmetry or malposition came in around 3.9%. Compared to cisgender women, trans women had higher rates of hematoma/seroma and implant asymmetry, but capsular contracture and infection rates were similar.7PubMed. Complications following Breast Augmentation in Transfeminine Individuals: A Systematic Review and Meta-Analysis
The elevated asymmetry rate ties back to the anatomical differences discussed earlier: wider chests, less native tissue, and broader spacing between breasts all make it harder to achieve perfect symmetry. The slightly higher hematoma rate could reflect differences in tissue vascularity or surgical technique adjustments needed for the trans anatomy.
Long-Term Follow-Up and Reoperation
A 30-year study from Amsterdam tracking 527 transgender women and nonbinary individuals who received breast implants provides some of the best long-term data available. Short-term complications requiring reoperation were uncommon: hematoma and infection each occurred in less than half a percent of patients. The longer-term picture showed implant rupture in about 5.7% and capsular contracture in about 4.9%, both of which are in the same general range seen in cisgender augmentation. About 3.8% had aesthetic revisions, and 2.5% came back requesting larger implants.8PubMed. Long-term Follow-up and Trends in Breast Augmentation in 527 Transgender Women and Nonbinary Individuals: A 30-year experience in Amsterdam
A separate study found that about 5% of trans women required reoperation due to complications overall, with capsular contracture (at the grades that cause symptoms or visible distortion) sitting around 3%.9PubMed Central. Complications and satisfaction in transwomen receiving breast augmentation: short- and long-term outcomes These numbers are worth keeping in mind when setting expectations: breast implants are not necessarily a one-and-done procedure, and you should plan for the possibility of a revision at some point down the line, whether that is for a complication or simply because implants do not last forever.
Recovery and the Effect on Chest Strength
For anyone who trains their chest regularly, the question of whether implants affect pectoral strength matters a lot. The answer depends on where the implant sits. Subpectoral placement, where the implant goes behind the pectoralis major muscle, is the most common approach for both cosmetic and gender-affirming breast augmentation. It provides better coverage of the implant but requires the surgeon to partially release the muscle from its lower attachment.
One study tracking upper-body strength after subpectoral breast augmentation found that strength dropped significantly at two weeks post-surgery. By six weeks, more than three-quarters of patients had returned to their baseline. Long-term follow-up revealed no permanent loss of strength.10Aesthetic Surgery Journal. Strength Performance of the Pectoralis Major Muscle After Subpectoral Breast Augmentation Surgery However, a different study looking at subpectoral implant placement (in the context of post-mastectomy reconstruction, which involves more tissue disruption) found a roughly 20% reduction in torque strength on the operated side after correcting for hand dominance. That study cautioned that surgeons should minimize the amount of pectoral muscle release and discuss the possible deficit beforehand.11Annals of Plastic Surgery. Function of the Pectoralis Major Muscle After Combined Skin-Sparing Mastectomy and Immediate Reconstruction by Subpectoral Implantation of a Prosthesis
The gap between these two findings likely reflects the extent of surgery. A cosmetic augmentation typically requires less muscle disruption than a full mastectomy reconstruction. For cisgender men getting pectoral implants, the solid silicone device sits in a pocket created behind the muscle, and the muscle itself is generally left more intact than in breast augmentation. Still, if you are a gym-goer or athlete, expect at least a few weeks of restricted upper-body training and a period where pressing and fly movements feel weaker.
A Rare but Serious Risk Worth Knowing About
Breast implant-associated anaplastic large cell lymphoma, known as BIA-ALCL, is a rare type of lymphoma linked to textured breast implants. It develops in the scar tissue and fluid around the implant, not in the breast tissue itself. The condition has been documented in cisgender women, and there have been at least four reported cases in transgender women as well.12PubMed Central. Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient Population
One review of those cases found that the average time from implant placement to BIA-ALCL diagnosis was about 12 years, with symptoms appearing around 5 years before diagnosis. This timeline from first symptoms was similar to what is seen in cisgender patients, but the overall time to diagnosis tended to be shorter, possibly because the cases that were identified happened to present at earlier stages or because the population is younger on average. Most of the trans women who developed BIA-ALCL presented with a palpable mass near the implant rather than the more common first sign seen in cisgender patients, which is a painless fluid collection.13PubMed Central. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in a young transgender woman: A case report
The concern with trans women is that they are less likely to be enrolled in structured follow-up programs. Cisgender women who receive implants after breast cancer reconstruction often have regular imaging and oncology check-ins. Trans women and cisgender men with pectoral implants typically do not. That gap means swelling or masses around the implant might not get evaluated as promptly. If you have any type of breast or chest implant and notice new swelling, firmness, or a lump near the implant years after placement, getting it checked promptly is important. The condition can even mimic other problems: one case report described a trans patient whose late hematoma presented with symptoms nearly identical to BIA-ALCL, requiring surgical removal and pathology to tell the difference.14PubMed Central. Late Hematoma After Feminizing Augmentation Mammoplasty Mimicking Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Screening and Imaging After Implants
Breast cancer screening for anyone with implants is an area where guidance is still evolving. For transgender women, screening mammography has been suggested when risk factors are present, including having received feminizing hormone therapy for more than five years. But this recommendation is not yet backed by the same depth of evidence as screening guidelines for cisgender women, and the actual breast cancer risk in trans women with implants is still being defined.15PubMed Central. Breast Imaging of Transgender Individuals: A Review
For cisgender men with pectoral implants, routine breast imaging is not standard practice. Male breast cancer is rare to begin with, and the solid silicone pectoral implant sits in a different anatomical position than a traditional breast implant. That said, any new breast or chest symptoms, including lumps, skin changes, or nipple discharge, should prompt a clinical evaluation regardless of the type of implant present.
The Psychology of Seeking Chest Changes
Men considering pectoral implants do not necessarily dislike their overall appearance. One study that assessed body image in male cosmetic surgery patients before their initial consultation found that their general body satisfaction was no different from men in a normative sample. Where they diverged sharply was in dissatisfaction with the specific feature they were seeking surgery for. In other words, these were not men with broad self-image problems; they had a focused concern about one body part that bothered them enough to pursue surgery.
For trans women, the psychological stakes are layered differently. Breast augmentation is part of aligning physical appearance with gender identity, and the distress driving the decision typically reflects gender dysphoria rather than isolated cosmetic dissatisfaction. Research has documented that gender-affirming surgeries can improve quality of life and reduce psychiatric distress, though the evidence base is still growing and outcomes vary from person to person.16PubMed Central. Impact of Gender-Affirming Surgery on Psychiatric Outcomes and Quality of Life in Transgender Individuals: A Systematic Review of Longitudinal Cohort Studies
Insurance Coverage and Access
If you are a cisgender man seeking pectoral implants for cosmetic reasons, insurance will not cover the procedure. It is classified as elective cosmetic surgery, and you should expect to pay entirely out of pocket.
For transgender women, the insurance landscape is more complicated and often frustrating. Many insurers classify breast augmentation as cosmetic regardless of the patient’s gender identity, equating it with a cisgender woman wanting larger breasts. The billing code used for the procedure is the same standard cosmetic augmentation code, which does not distinguish between cosmetic and gender-affirming intent. Advocates and many surgeons argue that for trans women, the procedure is reconstructive rather than cosmetic, and should be covered accordingly.17PubMed Central. Navigating Insurance Policies in the United States for Gender-affirming Surgery Coverage varies widely by insurer, state, and individual plan. Some plans now cover gender-affirming breast augmentation, while others require extensive documentation, prior authorization, or appeals. If you are navigating this process, working with a surgeon’s office experienced in gender-affirming care and insurance appeals can save significant time.
Access disparities go beyond insurance. The database study comparing outcomes between cisgender and trans women noted that trans women in the sample had higher rates of smoking, diabetes, and hypertension, which reflects broader health disparities in the transgender population.6PubMed Central. A comparison of perioperative safety for breast augmentation in cis- vs. trans patients These factors can complicate surgical planning and recovery, even though the actual complication rates turned out to be comparable once surgery was performed. Surgeons experienced with the trans population know how to optimize patients beforehand, including smoking cessation support and blood pressure management, to keep risk in line with the general augmentation population.
Pectoral Implants Versus Breast Implants as Devices
It is worth being clear about the physical difference between the two types of implants, because the names are sometimes used loosely. A pectoral implant, the kind placed in cisgender men for chest enhancement, is a carved block of solid silicone rubber. It does not have a shell filled with gel or saline. It is firm, it holds its shape on its own, and it is designed to mimic the contour of a well-developed pectoralis muscle. A breast implant, used in both cisgender and transgender breast augmentation, is a flexible shell filled with either silicone gel or saline. It is designed to mimic the softness and movement of natural breast tissue.
Because of these differences, the failure modes are different too. A breast implant can rupture, leaking its contents into the surrounding tissue. A pectoral implant cannot rupture in the same way since there is nothing inside it to leak. Instead, the main failure mode for pectoral implants is displacement or extrusion. The solid block can shift out of position, especially if the pocket created during surgery is too large or if the patient returns to heavy bench pressing too early. Imaging for pectoral implant complications is uncommon enough that radiologists may not immediately recognize what they are seeing, which can delay diagnosis.